Replies to post #981 on Alaunos Therapeutics Inc (TCRT)

[growacet]

I don't post anything like Rob.....

No outlandish claims, negative or positive. ZIOP is running out of cash, that's a fact, fully disclosed in their filings. This ph I trial they just PR'd the results about is estimated to have a study completion date of December 2018, a full year after their filings say they expect to be out of cash.

Long investors think that a partnership, a merger or a buyout will come to the rescue before the cash register is empty, and maybe it will be....that's speculation but it isn't fact.

No question ZIOP is an amazing trading vehicle....But as a long term hold I see it as being massive risk and grossly overvalued based on the fundamentals. Weak cash position, paying big bucks to guys like the CEO, and nothing in late stage development.